Paper20049949
Direct comparison of two different mesalamine formulations for the maintenance of remission in patients with ulcerative colitis: a double-blind, randomized study.
Ito H and 7 others. Inflamm Bowel Dis, 2010. Cited by 20 papers, by iCite.
Cite this record
ConductScience Library. Direct comparison of two different mesalamine formulations for the maintenance of remission in patients with ulcerative colitis: a double-blind, randomized study. Papers, record 20049949. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20049949
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Direct comparison of two different mesalamine formulations for the maintenance of remission in patients with ulcerative colitis: a double-blind, randomized study.
- PubMed
- Publication types
- Comparative Study, Journal Article, Multicenter Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Inflammatory Agents, Non-Steroidal | Major topic |
| Colitis, Ulcerative | Major topic |
| Mesalamine | Major topic |
| Pharmaceutical Preparations | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Chemistry, Pharmaceutical | |
| Double-Blind Method | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Hydrogen-Ion Concentration | |
| Male | |
| Middle Aged | |
| Remission Induction | |
| Severity of Illness Index | |
| Survival Rate | |
| Time Factors | |
| Treatment Outcome | |
| Young Adult |
Source PubMed
References16
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15929768 | Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies. | Am J Gastroenterol | 2005 | https://conductscience.org/library/papers/15929768 | PubMed |
| 2 | 8533995 | An oral preparation of mesalamine as long-term maintenance therapy for ulcerative colitis. A randomized, placebo-controlled trial. The Mesalamine Study Group. | Ann Intern Med | 1996 | https://conductscience.org/library/papers/8533995 | PubMed |
| 3 | 3569765 | 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis. | Gastroenterology | 1987 | https://conductscience.org/library/papers/3569765 | PubMed |
| 4 | 15233681 | Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee. | Am J Gastroenterol | 2004 | https://conductscience.org/library/papers/15233681 | PubMed |
| 5 | 3678967 | Effect of polymer coating on faecal recovery of ingested 5-amino salicylic acid in patients with ulcerative colitis. | Gut | 1987 | https://conductscience.org/library/papers/3678967 | PubMed |
| 6 | 14075156 | VARIATION BETWEEN OBSERVERS IN DESCRIBING MUCOSAL APPEARANCES IN PROCTOCOLITIS. | Br Med J | 1964 | https://conductscience.org/library/papers/14075156 | PubMed |
| 7 | 26193460 | A critical review of endoscopic indices in ulcerative colitis: inter-observer variation of the endoscopic index. | Clin J Gastroenterol | 2008 | https://conductscience.org/library/papers/26193460 | PubMed |
| 8 | 11151878 | Intravenous azathioprine in severe ulcerative colitis: a pilot study. | Am J Gastroenterol | 2000 | https://conductscience.org/library/papers/11151878 | PubMed |
| 9 | 7851193 | Safety and efficacy of controlled-release mesalamine for maintenance of remission in ulcerative colitis. Pentasa UC Maintenance Study Group. | Dig Dis Sci | 1995 | https://conductscience.org/library/papers/7851193 | PubMed |
| 10 | 2684592 | Mesalazine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in chronic inflammatory bowel disease. | Drugs | 1989 | https://conductscience.org/library/papers/2684592 | PubMed |
| 11 | 11515848 | Measurement of colonic mucosal concentrations of 5-aminosalicylic acid is useful for estimating its therapeutic efficacy in distal ulcerative colitis: comparison of orally administered mesalamine and sulfasalazine. | Inflamm Bowel Dis | 2001 | https://conductscience.org/library/papers/11515848 | PubMed |
| 12 | 3557190 | Metabolism and urinary excretion of 5-amino salicylic acid in healthy volunteers when given intravenously or released for absorption at different sites in the gastrointestinal tract. | Gut | 1987 | https://conductscience.org/library/papers/3557190 | PubMed |
| 13 | 15306569 | Guidelines for the management of inflammatory bowel disease in adults. | Gut | 2004 | https://conductscience.org/library/papers/15306569 | PubMed |
| 14 | 3317057 | Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study. | N Engl J Med | 1987 | https://conductscience.org/library/papers/3317057 | PubMed |
| 15 | 3207553 | Delayed-release mesalazine (5-aminosalicylic acid): coat dissolution and excretion in ileostomy subjects. | Br J Clin Pharmacol | 1988 | https://conductscience.org/library/papers/3207553 | PubMed |
| 16 | 15994215 | 5-Aminosalicylate use and colorectal cancer risk in inflammatory bowel disease: a large epidemiological study. | Gut | 2005 | https://conductscience.org/library/papers/15994215 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 20 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 34631051 | pH-dependent vs. constant release of mesalazine in the treatment of ulcerative colitis: Do drug delivery concepts determine therapeutic efficacy? (Review). | Biomed Rep | 2021 | https://conductscience.org/library/papers/34631051 | PubMed |
| 32856298 | Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis. | Cochrane Database Syst Rev | 2020 | https://conductscience.org/library/papers/32856298 | PubMed |
| 32778960 | Solving the questions regarding 5-aminosalitylate formulation in the treatment of ulcerative colitis. | J Gastroenterol | 2020 | https://conductscience.org/library/papers/32778960 | PubMed |
| 30576644 | AGA Clinical Practice Guidelines on the Management of Mild-to-Moderate Ulcerative Colitis. | Gastroenterology | 2019 | https://conductscience.org/library/papers/30576644 | PubMed |
| 30576642 | AGA Technical Review on the Management of Mild-to-Moderate Ulcerative Colitis. | Gastroenterology | 2019 | https://conductscience.org/library/papers/30576642 | PubMed |
| 30122356 | Comparative efficacy and tolerability of pharmacological agents for management of mild to moderate ulcerative colitis: a systematic review and network meta-analyses. | Lancet Gastroenterol Hepatol | 2018 | https://conductscience.org/library/papers/30122356 | PubMed |
| 28670233 | Comparison of efficacies of once-daily dose multimatrix mesalazine and multiple-dose mesalazine for the maintenance of remission in ulcerative colitis: a randomized, double-blind study. | Intest Res | 2017 | https://conductscience.org/library/papers/28670233 | PubMed |
| 28390410 | Real life results in using 5-ASA for maintaining mild to moderate UC patients in Japan, a multi-center study, OPTIMUM Study. | BMC Gastroenterol | 2017 | https://conductscience.org/library/papers/28390410 | PubMed |
| 28368909 | 2.4 g Mesalamine (Asacol 400 mg tablet) Once Daily is as Effective as Three Times Daily in Maintenance of Remission in Ulcerative Colitis: A Randomized, Noninferiority, Multi-center Trial. | Inflamm Bowel Dis | 2017 | https://conductscience.org/library/papers/28368909 | PubMed |
| 27158764 | Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis. | Cochrane Database Syst Rev | 2016 | https://conductscience.org/library/papers/27158764 | PubMed |
| 22390554 | Mesalamine in the treatment and maintenance of remission of ulcerative colitis. | Expert Rev Clin Pharmacol | 2012 | https://conductscience.org/library/papers/22390554 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CRP | 1401 | PubTator's text mining | https://conductscience.org/library/genes/1401 | NCBI Gene |
| FAS | 355 | PubTator's text mining | https://conductscience.org/library/genes/355 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20049949
GET https://conductscience.org/api/papers/v1/20049949/authors